zanamivir has been researched along with Nervous System Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Falahee, ML; Vallerand, AH; Vantine, M | 1 |
Kashiwagi, S; Mitsui, N; Niwa, S; Shiosakai, K; Shiozawa, T; Tanigawa, M; Yamaguchi, F; Yamaguchi, H; Yamanouchi, N; Yoshida, S | 1 |
1 review(s) available for zanamivir and Nervous System Disorders
Article | Year |
---|---|
Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance.
Topics: Antiviral Agents; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Guanidines; Humans; Japan; Mental Disorders; Nervous System Diseases; Product Surveillance, Postmarketing; Pyrans; Sialic Acids; Zanamivir | 2012 |
1 other study(ies) available for zanamivir and Nervous System Disorders
Article | Year |
---|---|
Neuropsychiatric concerns related to influenza treatment.
Topics: Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Mental Disorders; Nervous System Diseases; Oseltamivir; Zanamivir | 2009 |